IFNG and neoplasm: In addition, JQ1, which is an inhibitor of the bromodomain and extra terminal domain, has been shown to downregulate PD-L1 expression in tumor cells, macrophages, and dendritic cells (DCs) and increase cytotoxic T-cell activity and IFN-γ secretion (96).